PROGRAM
29
April
Tuesday
ESH MASTERPLAN for hypertension management in CKD
SLOT 1
(2 sessions with the same content)
SLOT 1
(2 sessions with the same content)
CHAIRPERSONS
Reinhold Kreutz (Germany)
Liffert Vogt (The Netherlands)
Liffert Vogt (The Netherlands)
12:00pm
- 12:01pm
INTRODUCTION
Reinhold
Kreutz (Germany)
12:01pm
- 12:14pm
MEASURE BP –DIAGNOSE AND ASSESS PATIENT
BP measurements including ABPM, and the role of measuring uACR
BP measurements including ABPM, and the role of measuring uACR
Lene
Halvorsen (Norway)
12:14pm
- 12:27pm
SELECT THERAPY
BP treatment in patients with CKD including SGLT2i and nsMRA.
BP treatment in patients with CKD including SGLT2i and nsMRA.
Pantelis Sarafidis (Greece)
12:27pm
- 12:40pm
EVALUATE RESPONSE
Evaluation and consideration during the initiation phase, short-term and long-term follow up
Evaluation and consideration during the initiation phase, short-term and long-term follow up
Liffert
Vogt (The Netherlands)
12:40pm
- 1:00pm
DISCUSSION
29
April
Tuesday
ESH MASTERPLAN for hypertension management in CKD
SLOT 2
(2 sessions with the same content)
SLOT 2
(2 sessions with the same content)
CHAIRPERSONS
Reinhold Kreutz (Germany)
Liffert Vogt (The Netherlands)
5:00pm
- 5:01pm
INTRODUCTION
Reinhold
Kreutz (Germany)
5:01pm
- 5:14pm
MEASURE BP –DIAGNOSE AND ASSESS PATIENT
BP measurements including ABPM, and the role of measuring uACR
BP measurements including ABPM, and the role of measuring uACR
Lene
Halvorsen (Norway)
5:14pm
- 5:27pm
SELECT THERAPY
BP treatment in patients with CKD including SGLT2i and nsMRA.
BP treatment in patients with CKD including SGLT2i and nsMRA.
Pantelis Sarafidis (Greece)
5:27pm
- 5:40pm
EVALUATE RESPONSE
Evaluation and consideration during the initiation phase, short-term and long-term follow up
Evaluation and consideration during the initiation phase, short-term and long-term follow up
Liffert
Vogt (The Netherlands)
5:40pm
- 6:00pm
DISCUSSION